Basic Information | Post buying leads | Suppliers |
Name |
Omeprazole sodium |
EINECS | 623-285-9 |
CAS No. | 95510-70-6 | Density | 1.37g/cm3 |
PSA | 94.68000 | LogP | 3.48690 |
Solubility | N/A | Melting Point |
N/A |
Formula | C17H18N3NaO3S | Boiling Point | 600oC at 760mmHg |
Molecular Weight | 368.412 | Flash Point | 316.7oC |
Transport Information | N/A | Appearance | Clear in water |
Safety | Risk Codes | N/A | |
Molecular Structure | Hazard Symbols | N/A | |
Synonyms |
1H-Benzimidazole,5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-, sodium salt (9CI);(±)-Omeprazole sodium salt;5-Methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridyl)methyl]sulfinyl]-1H-benzimidazolesodium salt;5-Methoxy-2-[[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl]-1H-benzimidazolesodium salt;H 168/68 sodium;Losec Sodium;Omeprazolesodium salt;Sodium 5-methoxy-2-[(4-methoxy-3,5-dimethyl-pyridin-2-yl)methylsulfinyl]benzoimidazole; |
The Omeprazole sodium, with the CAS registry number 95510-70-6, is also known as Sodium 5-methoxy-2-[(4-methoxy-3,5-dimethyl-pyridin-2-yl)methylsulfinyl]benzoimidazole. It belongs to the product categories of Active Pharmaceutical Ingredients; Omeprazole. This chemical's molecular formula is C17H18N3NaO3S and molecular weight is 368.41. Its classification codes are: (1)Antisecretory [gastric]; (2)Drug / Therapeutic Agent; (3)Reproductive Effect.
Physical properties of Omeprazole sodium are: (1)#H bond acceptors: 6; (2)#H bond donors: 1; (3)#Freely Rotating Bonds: 5; (4)Polar Surface Area: 96.31 Å2.
You can still convert the following datas into molecular structure:
(1)SMILES: [Na+].Cc3c(OC)c(C)cnc3CS(=O)c1nc2ccc(cc2n1)OC
(2)Std. InChI: InChI=1S/C17H19N3O3S.Na/c1-10-8-18-15(11(2)16(10)23-4)9-24(21)17-19-13-6-5-12(22-3)7-14(13)20-17;/h5-8H,9H2,1-4H3,(H,19,20);/q;+1
(3)Std. InChIKey: KNVABRFVZVESIL-UHFFFAOYSA-N
The toxicity data is as follows:
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
dog | LDLo | intravenous | 400mg/kg (400mg/kg) | BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) GASTROINTESTINAL: CHANGES IN STRUCTURE OR FUNCTION OF SALIVARY GLANDS | Oyo Yakuri. Pharmacometrics. Vol. 49, Pg. 497, 1995. |
rat | LD50 | intravenous | 278mg/kg (278mg/kg) | BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) LUNGS, THORAX, OR RESPIRATION: DYSPNEA | Oyo Yakuri. Pharmacometrics. Vol. 49, Pg. 479, 1995. |